Dolca Thomas

Statistics

Publications

Citations

451

H-Index

Active since

2010

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of California, San Francisco

Bellvitge University Hospital

Lakeshore Hospital

Sharp Memorial Hospital

Dolca Thomas is an author at Bristol-Myers Squibb (United States) specializing in immunosuppression in kidney transplantation, kidney transplantation, and medicine.

Publications per year

2010–2012

Publications

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients

Lionel Rostaing, P. Massari, Valter Duro Garcı́a et al. · Clinical Journal of the American Society of Nephrology · 2010 · 185 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients

Josep M. Grinyó, Bernard Charpentier, José Medina‐Pestana et al. · Transplantation · 2010 · 123 citations

Medicine, Pharmacology, Pharmacotherapy +15

Lymphoproliferative Disorders After Adult Kidney Transplant: Epidemiology and Comparison of Registry Report With Claims-Based Diagnoses

Bertram L. Kasiske, Aleksandra Kukla, Dolca Thomas et al. · American Journal of Kidney Diseases · 2011 · 55 citations

Medicine, Hematology, Nephrology +15

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study

Josep M. Grinyó, Josefina Alberú, F.L.C. Contieri et al. · Transplant International · 2012 · 53 citations · Full text

Medicine, Nephrology, Pharmacology +14

Belatacept-versus Cyclosporine-Based Immunosuppression in Renal Transplant Recipients with Pre-existing Diabetes

Lionel Rostaing, H. H. Neumayer, Rafael Reyes‐Acevedo et al. · Clinical Journal of the American Society of Nephrology · 2011 · 35 citations · Full text

Medicine, Nephrology, Pharmacotherapy +12

1–5 of 5